Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 184

1.

Australian consensus statement for best practice ROS1 testing in advanced non-small cell lung cancer.

Pavlakis N, Cooper C, John T, Kao S, Klebe S, Lee CK, Leong T, Millward M, O'Byrne K, Russell PA, Solomon B, Cooper WA, Fox S.

Pathology. 2019 Dec;51(7):673-680. doi: 10.1016/j.pathol.2019.08.006. Epub 2019 Oct 24.

PMID:
31668406
2.

Unstable TTTTA/TTTCA expansions in MARCH6 are associated with Familial Adult Myoclonic Epilepsy type 3.

Florian RT, Kraft F, Leitão E, Kaya S, Klebe S, Magnin E, van Rootselaar AF, Buratti J, Kühnel T, Schröder C, Giesselmann S, Tschernoster N, Altmueller J, Lamiral A, Keren B, Nava C, Bouteiller D, Forlani S, Jornea L, Kubica R, Ye T, Plassard D, Jost B, Meyer V, Deleuze JF, Delpu Y, Avarello MDM, Vijfhuizen LS, Rudolf G, Hirsch E, Kroes T, Reif PS, Rosenow F, Ganos C, Vidailhet M, Thivard L, Mathieu A, Bourgeron T, Kurth I, Rafehi H, Steenpass L, Horsthemke B; FAME consortium, LeGuern E, Klein KM, Labauge P, Bennett MF, Bahlo M, Gecz J, Corbett MA, Tijssen MAJ, van den Maagdenberg AMJM, Depienne C.

Nat Commun. 2019 Oct 29;10(1):4919. doi: 10.1038/s41467-019-12763-9.

3.

EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach.

Nicholson AG, Sauter JL, Nowak AK, Kindler HL, Gill RR, Remy-Jardin M, Armato SG 3rd, Fernandez-Cuesta L, Bueno R, Alcala N, Foll M, Pass H, Attanoos R, Baas P, Beasley MB, Brcic L, Butnor KJ, Chirieac LR, Churg A, Courtiol P, Dacic S, De Perrot M, Frauenfelder T, Gibbs A, Hirsch FR, Hiroshima K, Husain A, Klebe S, Lantuejoul S, Moreira A, Opitz I, Perol M, Roden A, Roggli V, Scherpereel A, Tirode F, Tazelaar H, Travis WD, Tsao MS, van Schil P, Vignaud JM, Weynand B, Cree I, Rusch VW, Girard N, Galateau-Salle F.

J Thorac Oncol. 2019 Sep 20. pii: S1556-0864(19)33232-0. doi: 10.1016/j.jtho.2019.08.2506. [Epub ahead of print]

PMID:
31546041
4.

Examining the Reserve Hypothesis in Parkinson's Disease: A Longitudinal Study.

Lee PC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, Marques AR, Bourdain F, Brandel JP, Pico F, Lacomblez L, Bonnet C, Brefel-Courbon C, Ory-Magne F, Grabli D, Klebe S, Mangone G, You H, Mesnage V, Brice A, Vidailhet M, Corvol JC, Elbaz A; DIGPD Study Group.

Mov Disord. 2019 Nov;34(11):1663-1671. doi: 10.1002/mds.27854. Epub 2019 Sep 13.

PMID:
31518456
5.

Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel.

Marchevsky AM, Khoor A, Walts AE, Nicholson AG, Zhang YZ, Roggli V, Carney J, Roden AC, Tazelaar HD, Larsen BT, LeStang N, Chirieac LR, Klebe S, Tsao MS, De Perrot M, Pierre A, Hwang DM, Hung YP, Mino-Kenudson M, Travis W, Sauter J, Beasley MB, Galateau-Sallé F.

Mod Pathol. 2019 Sep 4. doi: 10.1038/s41379-019-0352-3. [Epub ahead of print]

PMID:
31485011
6.

Sex differences in corneal neovascularization in response to superficial corneal cautery in the rat.

Irani YD, Pulford E, Mortimer L, Irani S, Butler L, Klebe S, Williams KA.

PLoS One. 2019 Sep 3;14(9):e0221566. doi: 10.1371/journal.pone.0221566. eCollection 2019.

7.

Interobserver variation in the assessment of the sarcomatoid and transitional components in biphasic mesotheliomas.

Dacic S, Le Stang N, Husain A, Weynand B, Beasley MB, Butnor K, Chapel D, Gibbs A, Klebe S, Lantuejoul S, Roden AC, Roggli V, Tazelaar H, Vignaud JM, Galateau-Sallé F.

Mod Pathol. 2019 Jul 4. doi: 10.1038/s41379-019-0320-y. [Epub ahead of print]

PMID:
31273316
8.

Reduced expression of apolipoprotein E and immunoglobulin heavy constant gamma 1 proteins in Fuchs endothelial corneal dystrophy.

Kuot A, Ronci M, Mills R, Klebe S, Snibson G, Wiffen S, Loh R, Corbett M, Zhou T, Chataway T, Burdon KP, Craig JE, Urbani A, Sharma S.

Clin Exp Ophthalmol. 2019 Jun 17. doi: 10.1111/ceo.13569. [Epub ahead of print]

PMID:
31206232
9.

The Incidence of Labelling of Non-Lung Adenocarcinomas With Antibodies Against TTF-1 and Diagnostic Implications.

Prabhakaran S, Woo WLW, Xing G, Moffat D, Hussey M, Henderson DW, Klebe S.

Appl Immunohistochem Mol Morphol. 2019 May 23. doi: 10.1097/PAI.0000000000000775. [Epub ahead of print]

PMID:
31135446
10.

DMAPT is an Effective Radioprotector from Long-Term Radiation-Induced Damage to Normal Mouse Tissues In Vivo.

Morel KL, Ormsby RJ, Klebe S, Sweeney CJ, Sykes PJ.

Radiat Res. 2019 Aug;192(2):231-239. doi: 10.1667/RR15404.1. Epub 2019 May 16.

PMID:
31095445
11.

A Tribute to Professor Douglas Warrington Henderson, AO, MB, BS, FRCPA, FRCPath, FHKCPath (Hon): 1942-2018.

Klebe S.

Arch Pathol Lab Med. 2019 May;143(5):547. doi: 10.5858/arpa.2018-0592-LE. No abstract available.

PMID:
31026218
12.

When RON MET TAM in Mesothelioma: All Druggable for One, and One Drug for All?

Baird AM, Easty D, Jarzabek M, Shiels L, Soltermann A, Klebe S, Raeppel S, MacDonagh L, Wu C, Griggs K, Kirschner MB, Stanfill B, Nonaka D, Goparaju CM, Murer B, Fennell DA, O'Donnell DM, Barr MP, Mutti L, Reid G, Finn S, Cuffe S, Pass HI, Opitz I, Byrne AT, O'Byrne KJ, Gray SG.

Front Endocrinol (Lausanne). 2019 Feb 26;10:89. doi: 10.3389/fendo.2019.00089. eCollection 2019.

13.

Atypical Presentation of Rapid-onset Dystonia-parkinsonism (DYT12) Unresponsive to Deep Brain Stimulation of the Subthalamic Nucleus.

Weber J, Piroth T, Rijntjes M, Jung B, Reinacher PC, Weiller C, Coenen VA, Klebe S.

Mov Disord Clin Pract. 2018 Apr 1;5(4):427-429. doi: 10.1002/mdc3.12605. eCollection 2018 Jul-Aug. No abstract available.

14.

Management of delirium in Parkinson's disease.

Ebersbach G, Ip CW, Klebe S, Koschel J, Lorenzl S, Schrader C, Winkler C, Franke C.

J Neural Transm (Vienna). 2019 Jul;126(7):905-912. doi: 10.1007/s00702-019-01980-7. Epub 2019 Feb 6. Review.

PMID:
30725186
15.

Novel protein constituents of pathological ocular pseudoexfoliation syndrome deposits identified with mass spectrometry.

Sharma S, Chataway T, Klebe S, Griggs K, Martin S, Chegeni N, Dave A, Zhou T, Ronci M, Voelcker NH, Mills RA, Craig JE.

Mol Vis. 2018 Dec 28;24:801-817. eCollection 2018.

16.

Chorea-Acanthocytosis Presenting as Autosomal Recessive Epilepsy in a Family With a Novel VPS13A Mutation.

Weber J, Frings L, Rijntjes M, Urbach H, Fischer J, Weiller C, Meyer PT, Klebe S.

Front Neurol. 2019 Jan 9;9:1168. doi: 10.3389/fneur.2018.01168. eCollection 2018.

17.

[Genetics of movement disorders-rare but important].

Klebe S, Timmann D.

Nervenarzt. 2019 Feb;90(2):197-210. doi: 10.1007/s00115-018-0659-1. Review. German.

PMID:
30645659
18.

The Combination of Metformin and Valproic Acid Has a Greater Anti-tumoral Effect on Prostate Cancer Growth In Vivo than Either Drug Alone.

Tran LNK, Kichenadasse G, Morel KL, Lavranos TC, Klebe S, Lower KM, Ormsby RJ, Elliot DJ, Sykes PJ.

In Vivo. 2019 Jan-Feb;33(1):99-108. doi: 10.21873/invivo.11445.

19.

Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.

Walpole S, Pritchard AL, Cebulla CM, Pilarski R, Stautberg M, Davidorf FH, de la Fouchardière A, Cabaret O, Golmard L, Stoppa-Lyonnet D, Garfield E, Njauw CN, Cheung M, Turunen JA, Repo P, Järvinen RS, van Doorn R, Jager MJ, Luyten GPM, Marinkovic M, Chau C, Potrony M, Höiom V, Helgadottir H, Pastorino L, Bruno W, Andreotti V, Dalmasso B, Ciccarese G, Queirolo P, Mastracci L, Wadt K, Kiilgaard JF, Speicher MR, van Poppelen N, Kilic E, Al-Jamal RT, Dianzani I, Betti M, Bergmann C, Santagata S, Dahiya S, Taibjee S, Burke J, Poplawski N, O'Shea SJ, Newton-Bishop J, Adlard J, Adams DJ, Lane AM, Kim I, Klebe S, Racher H, Harbour JW, Nickerson ML, Murali R, Palmer JM, Howlie M, Symmons J, Hamilton H, Warrier S, Glasson W, Johansson P, Robles-Espinoza CD, Ossio R, de Klein A, Puig S, Ghiorzo P, Nielsen M, Kivelä TT, Tsao H, Testa JR, Gerami P, Stern MH, Paillerets BB, Abdel-Rahman MH, Hayward NK.

J Natl Cancer Inst. 2018 Dec 1;110(12):1328-1341. doi: 10.1093/jnci/djy171. Review.

PMID:
30517737
20.

Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry.

Jo HE, Glaspole I, Goh N, Hopkins PMA, Moodley Y, Reynolds PN, Chapman S, Walters EH, Zappala C, Allan H, Macansh S, Grainge C, Keir GJ, Hayen A, Henderson D, Klebe S, Heinze SB, Miller A, Rouse HC, Duhig E, Cooper WA, Mahar AM, Ellis S, McCormack SR, Ng B, Godbolt DB, Corte TJ.

Respirology. 2019 Apr;24(4):361-368. doi: 10.1111/resp.13427. Epub 2018 Oct 17.

21.

Quantitative mass spectrometry to identify protein markers for diagnosis of malignant pleural mesothelioma.

White R, Pulford E, Elliot DJ, Thurgood LA, Klebe S.

J Proteomics. 2019 Feb 10;192:374-382. doi: 10.1016/j.jprot.2018.09.018. Epub 2018 Oct 6.

PMID:
30300743
22.

Pleural malignant mesothelioma versus pleuropulmonary synovial sarcoma: a clinicopathological study of 22 cases with molecular analysis and survival data.

Klebe S, Prabhakaran S, Hocking A, Pulford E, Moore S, Nicola M, Allen PW, Henderson DW.

Pathology. 2018 Oct;50(6):629-634. doi: 10.1016/j.pathol.2018.06.001. Epub 2018 Aug 28.

PMID:
30170702
23.

Administering Fixed Oral Doses of Curcumin to Rats through Voluntary Consumption.

Hocking AJ, Elliot D, Hua J, Klebe S.

J Am Assoc Lab Anim Sci. 2018 Sep 1;57(5):508-512. doi: 10.30802/AALAS-JAALAS-17-000143. Epub 2018 Aug 29.

24.

Retinal changes in Parkinson's disease and glaucoma.

Matlach J, Wagner M, Malzahn U, Schmidtmann I, Steigerwald F, Musacchio T, Volkmann J, Grehn F, Göbel W, Klebe S.

Parkinsonism Relat Disord. 2018 Nov;56:41-46. doi: 10.1016/j.parkreldis.2018.06.016. Epub 2018 Jun 21.

PMID:
29937099
25.

Chronic low dose ethanol induces an aggressive metastatic phenotype in TRAMP mice, which is counteracted by parthenolide.

Morel KL, Ormsby RJ, Solly EL, Tran LNK, Sweeney CJ, Klebe S, Cordes N, Sykes PJ.

Clin Exp Metastasis. 2018 Oct;35(7):649-661. doi: 10.1007/s10585-018-9915-9. Epub 2018 Jun 23.

PMID:
29936575
26.

Longitudinal analysis of impulse control disorders in Parkinson disease.

Corvol JC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, Marques AR, Bourdain F, Brandel JP, Pico F, Lacomblez L, Bonnet C, Brefel-Courbon C, Ory-Magne F, Grabli D, Klebe S, Mangone G, You H, Mesnage V, Lee PC, Brice A, Vidailhet M, Elbaz A; DIGPD Study Group.

Neurology. 2018 Jul 17;91(3):e189-e201. doi: 10.1212/WNL.0000000000005816. Epub 2018 Jun 20.

27.

New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi-Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center.

Galateau Salle F, Le Stang N, Nicholson AG, Pissaloux D, Churg A, Klebe S, Roggli VL, Tazelaar HD, Vignaud JM, Attanoos R, Beasley MB, Begueret H, Capron F, Chirieac L, Copin MC, Dacic S, Danel C, Foulet-Roge A, Gibbs A, Giusiano-Courcambeck S, Hiroshima K, Hofman V, Husain AN, Kerr K, Marchevsky A, Nabeshima K, Picquenot JM, Rouquette I, Sagan C, Sauter JL, Thivolet F, Travis WD, Tsao MS, Weynand B, Damiola F, Scherpereel A, Pairon JC, Lantuejoul S, Rusch V, Girard N.

J Thorac Oncol. 2018 Aug;13(8):1189-1203. doi: 10.1016/j.jtho.2018.04.023. Epub 2018 Apr 30.

28.

Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis.

Lannagan TRM, Lee YK, Wang T, Roper J, Bettington ML, Fennell L, Vrbanac L, Jonavicius L, Somashekar R, Gieniec K, Yang M, Ng JQ, Suzuki N, Ichinose M, Wright JA, Kobayashi H, Putoczki TL, Hayakawa Y, Leedham SJ, Abud HE, Yilmaz ÖH, Marker J, Klebe S, Wirapati P, Mukherjee S, Tejpar S, Leggett BA, Whitehall VLJ, Worthley DL, Woods SL.

Gut. 2019 Apr;68(4):684-692. doi: 10.1136/gutjnl-2017-315920. Epub 2018 Apr 17.

29.

Comprehensive analysis of the mutation spectrum in 301 German ALS families.

Müller K, Brenner D, Weydt P, Meyer T, Grehl T, Petri S, Grosskreutz J, Schuster J, Volk AE, Borck G, Kubisch C, Klopstock T, Zeller D, Jablonka S, Sendtner M, Klebe S, Knehr A, Günther K, Weis J, Claeys KG, Schrank B, Sperfeld AD, Hübers A, Otto M, Dorst J, Meitinger T, Strom TM, Andersen PM, Ludolph AC, Weishaupt JH; German ALS network MND-NET.

J Neurol Neurosurg Psychiatry. 2018 Aug;89(8):817-827. doi: 10.1136/jnnp-2017-317611. Epub 2018 Apr 12.

PMID:
29650794
30.

An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma.

Linton A, Cheng YY, Griggs K, Schedlich L, Kirschner MB, Gattani S, Srikaran S, Chuan-Hao Kao S, McCaughan BC, Klebe S, van Zandwijk N, Reid G.

Br J Cancer. 2018 Mar 20;118(6):e13. doi: 10.1038/bjc.2018.3. Epub 2018 Feb 13.

31.

Ataxia and autonomic dysfunction as presenting symptoms in late-onset Alexander disease.

Jost M, Rijntjes M, Urbach H, Egger K, Meyer PT, Frings L, Weiller C, Klebe S.

Neurol Clin Pract. 2017 Dec;7(6):523-526. doi: 10.1212/CPJ.0000000000000392. No abstract available.

32.

Severe camptocormia due to myositis of paraspinal muscles as an early manifestation of Parkinson's disease.

Whittaker K, Schroeter N, Rijntjes M, Guggenberger K, Lambeck J, Fritsch B, Weiller C, Meyer PT, Doostkam S, Klebe S.

Parkinsonism Relat Disord. 2018 Jan;46:95-97. doi: 10.1016/j.parkreldis.2017.11.008. Epub 2017 Nov 20. No abstract available.

PMID:
29174169
33.

Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma.

Johnson TG, Schelch K, Cheng YY, Williams M, Sarun KH, Kirschner MB, Kao S, Linton A, Klebe S, McCaughan BC, Lin RCY, Pirker C, Berger W, Lasham A, van Zandwijk N, Reid G.

J Thorac Oncol. 2018 Feb;13(2):258-272. doi: 10.1016/j.jtho.2017.10.016. Epub 2017 Nov 4.

34.

The Effect of Aquaporin 1-Inhibition on Vasculogenic Mimicry in Malignant Mesothelioma.

Pulford E, McEvoy J, Hocking A, Prabhakaran S, Griggs K, Klebe S.

Int J Mol Sci. 2017 Nov 1;18(11). pii: E2293. doi: 10.3390/ijms18112293.

35.

Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?

Pulford E, Huilgol K, Moffat D, Henderson DW, Klebe S.

Dis Markers. 2017;2017:1310478. doi: 10.1155/2017/1310478. Epub 2017 Sep 11.

36.

Oral Mucosal Epithelial Cells Grown on Porous Silicon Membrane for Transfer to the Rat Eye.

Irani YD, Klebe S, McInnes SJP, Jasieniak M, Voelcker NH, Williams KA.

Sci Rep. 2017 Aug 30;7(1):10042. doi: 10.1038/s41598-017-10793-1.

37.

The differential diagnosis between pleural sarcomatoid mesothelioma and spindle cell/pleomorphic (sarcomatoid) carcinomas of the lung: evidence-based guidelines from the International Mesothelioma Panel and the MESOPATH National Reference Center.

Marchevsky AM, LeStang N, Hiroshima K, Pelosi G, Attanoos R, Churg A, Chirieac L, Dacic S, Husain A, Khoor A, Klebe S, Lantuejoul S, Roggli V, Vignaud JM, Weynard B, Sauter J, Henderson D, Nabeshima K, Galateau-Salle F.

Hum Pathol. 2017 Sep;67:160-168. doi: 10.1016/j.humpath.2017.07.015. Epub 2017 Aug 4. Review.

PMID:
28782639
38.

An Anti-VEGF-B Antibody Fragment Induces Regression of Pre-Existing Blood Vessels in the Rat Cornea.

Irani YD, Scotney PD, Klebe S, Mortimer LA, Nash AD, Williams KA.

Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3404-3413. doi: 10.1167/iovs.16-21343.

PMID:
28692735
39.

Vasculogenic mimicry in vitro in tumour cells derived from metastatic malignant pleural effusions.

Sasanelli F, Hocking A, Pulford E, Irani Y, Klebe S.

Pathology. 2017 Aug;49(5):537-539. doi: 10.1016/j.pathol.2017.03.010. Epub 2017 Jul 6. No abstract available.

PMID:
28689631
40.

Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma.

Kao SC, Cheng YY, Williams M, Kirschner MB, Madore J, Lum T, Sarun KH, Linton A, McCaughan B, Klebe S, van Zandwijk N, Scolyer RA, Boyer MJ, Cooper WA, Reid G.

J Thorac Oncol. 2017 Sep;12(9):1421-1433. doi: 10.1016/j.jtho.2017.05.024. Epub 2017 Jun 16. Erratum in: J Thorac Oncol. 2018 Apr;13(4):587.

41.

Adult-Onset Niemann-Pick Disease Type C: Rapid Treatment Initiation Advised but Early Diagnosis Remains Difficult.

Piroth T, Boelmans K, Amtage F, Rijntjes M, Wierciochin A, Musacchio T, Weiller C, Volkmann J, Klebe S.

Front Neurol. 2017 Apr 4;8:108. doi: 10.3389/fneur.2017.00108. eCollection 2017.

42.

Genome-wide association study identifies three novel loci in Fuchs endothelial corneal dystrophy.

Afshari NA, Igo RP Jr, Morris NJ, Stambolian D, Sharma S, Pulagam VL, Dunn S, Stamler JF, Truitt BJ, Rimmler J, Kuot A, Croasdale CR, Qin X, Burdon KP, Riazuddin SA, Mills R, Klebe S, Minear MA, Zhao J, Balajonda E, Rosenwasser GO, Baratz KH, Mootha VV, Patel SV, Gregory SG, Bailey-Wilson JE, Price MO, Price FW Jr, Craig JE, Fingert JH, Gottsch JD, Aldave AJ, Klintworth GK, Lass JH, Li YJ, Iyengar SK.

Nat Commun. 2017 Mar 30;8:14898. doi: 10.1038/ncomms14898.

43.

Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.

Doppler K, Jentschke HM, Schulmeyer L, Vadasz D, Janzen A, Luster M, Höffken H, Mayer G, Brumberg J, Booij J, Musacchio T, Klebe S, Sittig-Wiegand E, Volkmann J, Sommer C, Oertel WH.

Acta Neuropathol. 2017 Apr;133(4):535-545. doi: 10.1007/s00401-017-1684-z. Epub 2017 Feb 8.

44.

Vasculogenic mimicry in malignant mesothelioma: an experimental and immunohistochemical analysis.

Pulford E, Hocking A, Griggs K, McEvoy J, Bonder C, Henderson DW, Klebe S.

Pathology. 2016 Dec;48(7):650-659. doi: 10.1016/j.pathol.2016.07.009. Epub 2016 Oct 29.

45.

Novel compound heterozygous synaptojanin-1 mutation causes l-dopa-responsive dystonia-parkinsonism syndrome.

Rauschendorf MA, Jost M, Stock F, Zimmer A, Rösler B, Rijntjes M, Piroth T, Coenen VA, Reinacher PC, Meyer PT, Frings L, Weiller C, Fischer J, Klebe S.

Mov Disord. 2017 Mar;32(3):478-480. doi: 10.1002/mds.26876. Epub 2016 Nov 21. No abstract available.

PMID:
27869329
46.

Genome-wide association study in essential tremor identifies three new loci.

Müller SH, Girard SL, Hopfner F, Merner ND, Bourassa CV, Lorenz D, Clark LN, Tittmann L, Soto-Ortolaza AI, Klebe S, Hallett M, Schneider SA, Hodgkinson CA, Lieb W, Wszolek ZK, Pendziwiat M, Lorenzo-Betancor O, Poewe W, Ortega-Cubero S, Seppi K, Rajput A, Hussl A, Rajput AH, Berg D, Dion PA, Wurster I, Shulman JM, Srulijes K, Haubenberger D, Pastor P, Vilariño-Güell C, Postuma RB, Bernard G, Ladwig KH, Dupré N, Jankovic J, Strauch K, Panisset M, Winkelmann J, Testa CM, Reischl E, Zeuner KE, Ross OA, Arzberger T, Chouinard S, Deuschl G, Louis ED, Kuhlenbäumer G, Rouleau GA.

Brain. 2016 Dec;139(Pt 12):3163-3169. Epub 2016 Oct 20.

47.

ALS and MMN mimics in patients with BSCL2 mutations: the expanding clinical spectrum of SPG17 hereditary spastic paraplegia.

Musacchio T, Zaum AK, Üçeyler N, Sommer C, Pfeifroth N, Reiners K, Kunstmann E, Volkmann J, Rost S, Klebe S.

J Neurol. 2017 Jan;264(1):11-20. doi: 10.1007/s00415-016-8301-2. Epub 2016 Oct 13.

PMID:
27738760
48.

Endobronchial Diagnosis of a Malignant Mesothelioma.

Yap HS, Klebe S, Rose A.

J Bronchology Interv Pulmonol. 2016 Jul;23(3):e30-2. doi: 10.1097/LBR.0000000000000294. No abstract available.

PMID:
27454480
49.

Early- and late-onset essential tremor patients represent clinically distinct subgroups.

Hopfner F, Ahlf A, Lorenz D, Klebe S, Zeuner KE, Kuhlenbäumer G, Deuschl G.

Mov Disord. 2016 Oct;31(10):1560-1566. doi: 10.1002/mds.26708.

PMID:
27384030
50.

Usefulness of Aquaporin 1 as a Prognostic Marker in a Prospective Cohort of Malignant Mesotheliomas.

Driml J, Pulford E, Moffat D, Karapetis C, Kao S, Griggs K, Henderson DW, Klebe S.

Int J Mol Sci. 2016 Jun 30;17(7). pii: E1041. doi: 10.3390/ijms17071041.

Supplemental Content

Support Center